About iBio CMO
IBio CMO: Pioneering the Future of Biologics Manufacturing and Development
iBio is a leading biotechnology company that specializes in the development and manufacturing of biologics using its proprietary FastPharming® System. The company has been at the forefront of innovation in this field, leveraging cutting-edge technology to create new treatments for a range of diseases.
The FastPharming® System is a plant-based platform that allows for rapid production of high-quality proteins, vaccines, and other biologics. This system has several advantages over traditional methods, including faster production times, lower costs, and greater scalability.
One key area where iBio has made significant progress is in the development of COVID-19 vaccines. The company's FastPharming® System was used to produce a vaccine candidate that showed promising results in preclinical trials. This vaccine could potentially be used to help combat the ongoing pandemic.
In addition to COVID-19 vaccines, iBio is also working on developing treatments for other diseases such as cancer and fibrosis. The company's expertise in biologics manufacturing makes it well-positioned to bring these treatments to market quickly and efficiently.
Another area where iBio excels is contract manufacturing services (CMO). The company offers a range of CMO services including process development, scale-up, cGMP manufacturing, fill-finish operations, and analytical testing. These services are provided through its subsidiary iBio CDMO LLC.
iBio's CMO services are highly sought after by pharmaceutical companies looking for reliable partners who can help them bring their products to market quickly and efficiently. With its state-of-the-art facilities and experienced team of scientists and engineers, iBio CDMO LLC is well-equipped to meet the needs of even the most demanding clients.
Overall, iBio is an innovative biotechnology company that is pioneering new approaches to biologics manufacturing and development. Its FastPharming® System has already shown great promise in producing COVID-19 vaccines as well as other important therapies. With its focus on quality control and customer satisfaction through its subsidiary iBio CDMO LLC., it's no wonder why so many pharmaceutical companies trust them with their projects!